BioXplor

BioXplor is developing an AI and network-based drug discovery platform for prioritization of drug combinations for complex diseases for pharma and biotech. The platform prioritises single assets or entire drug pipelines, with a unique safety and efficacy based prioritization model for multiple drug targets and drug com

BioXplor is active in the creative destruction lab company space based in United States.

Profile

BioXplor is developing an AI and network-based drug discovery platform for prioritization of drug combinations for complex diseases for pharma and biotech. The platform prioritises single assets or entire drug pipelines, with a unique safety and efficacy based prioritization model for multiple drug targets and drug combination candidates. In response to the pandemic, BioXplor is […]

Its activity falls under creative destruction lab company; the profile below is assembled from public directory data.

The company is recorded as being based in United States.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: bioxplor.com